Clinical Safety Profile of Sildenafil in Singaporean Men with Erectile Dysfunction: Pre-marketing Experience (ASSESS-I Evaluation)

Author： Lim PHC Ng FC Cheng CWS Wong MYC Chee CTY Moorthy P Vasan SS

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.30, Iss.2, 2002-03, pp. : 137-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Safety Profile of Dapoxetine during the Premarketing Evaluation

By Kowey Peter R.

Drugs in R&D, Vol. 11, Iss. 1, 2011-03 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

The Practice of Pre-Marketing Safety Assessment in Drug Development

By Chuang-Stein Christy Xia H. Amy

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 1, 2013-01 ,pp. : 3-25

Taylor & Francis Ltd

Access to resources Recommend Favorite

Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction

By Francis Sharron H Corbin Jackie D

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 2, 2005-08 ,pp. : 283-293

Informa Healthcare

Access to resources Recommend Favorite

Safety of sildenafil in the treatment of erectile dysfunction in patients with obstructive sleep apnoea

By Perimenis Petros Giannitsas Konstantinos

Expert Opinion on Drug Safety, Vol. 6, Iss. 4, 2007-07 ,pp. : 423-430

Informa Healthcare

Access to resources Recommend Favorite

Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 75-84

Informa Healthcare

Access to resources Recommend Favorite